Issue compulsory licences for manufacture of Ramdesivir, CPI(M) tells govt.

sfg-2026
ForumIAS LATEST
  1. 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
  2. 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
  3. 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
  4. 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
  5. 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
  6. 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →

News: CPI(Marxist) has said that the government should issue compulsory licences for the manufacture of a generic version of Remdesivir, an antiviral drug being used to treat COVID-19 patients.

Facts:

  • Compulsory licensing(CL): It is a process where a government allows someone else to produce the patented product or process without the consent of the patent owner. 
    • It is one of the flexibility on patent protection included in the WTO’s agreement on intellectual property –TRIPS  Agreement.
  • Section 84 of the (Indian) Patent Act,1970 provides that any time after three years from date of sealing of a patent, application for compulsory license can be made,provided:
    • the reasonable requirements of the public with respect to the patented invention have not been satisfied
    • the patented invention is not available to the public at a reasonably affordable price
    • patented invention has not worked in the territory of India.
  • Section 92 of the (Indian) Patent Act,1970 provides that compulsory licenses can also be issued by the Government if there is either a “national emergency” or “extreme urgency” or in cases of “public non-commercial use”.
Print Friendly and PDF
Blog
Academy
Community